548 related articles for article (PubMed ID: 18317232)
1. Carnitine supplementation induces acylcarnitine production in tissues of very long-chain acyl-CoA dehydrogenase-deficient mice, without replenishing low free carnitine.
Primassin S; Ter Veld F; Mayatepek E; Spiekerkoetter U
Pediatr Res; 2008 Jun; 63(6):632-7. PubMed ID: 18317232
[TBL] [Abstract][Full Text] [Related]
2. Tissue carnitine homeostasis in very-long-chain acyl-CoA dehydrogenase-deficient mice.
Spiekerkoetter U; Tokunaga C; Wendel U; Mayatepek E; Ijlst L; Vaz FM; van Vlies N; Overmars H; Duran M; Wijburg FA; Wanders RJ; Strauss AW
Pediatr Res; 2005 Jun; 57(6):760-4. PubMed ID: 15774826
[TBL] [Abstract][Full Text] [Related]
3. Changes in blood carnitine and acylcarnitine profiles of very long-chain acyl-CoA dehydrogenase-deficient mice subjected to stress.
Spiekerkoetter U; Tokunaga C; Wendel U; Mayatepek E; Exil V; Duran M; Wijburg FA; Wanders RJ; Strauss AW
Eur J Clin Invest; 2004 Mar; 34(3):191-6. PubMed ID: 15025677
[TBL] [Abstract][Full Text] [Related]
4. Carnitine supplementation induces long-chain acylcarnitine production--studies in the VLCAD-deficient mouse.
Liebig M; Gyenes M; Brauers G; Ruiter JP; Wendel U; Mayatepek E; Strauss AW; Wanders RJ; Spiekerkoetter U
J Inherit Metab Dis; 2006; 29(2-3):343-4. PubMed ID: 16763898
[TBL] [Abstract][Full Text] [Related]
5. Neonatal screening for very long-chain acyl-coA dehydrogenase deficiency: enzymatic and molecular evaluation of neonates with elevated C14:1-carnitine levels.
Liebig M; Schymik I; Mueller M; Wendel U; Mayatepek E; Ruiter J; Strauss AW; Wanders RJ; Spiekerkoetter U
Pediatrics; 2006 Sep; 118(3):1065-9. PubMed ID: 16950999
[TBL] [Abstract][Full Text] [Related]
6. Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders.
Djouadi F; Aubey F; Schlemmer D; Ruiter JP; Wanders RJ; Strauss AW; Bastin J
Hum Mol Genet; 2005 Sep; 14(18):2695-703. PubMed ID: 16115821
[TBL] [Abstract][Full Text] [Related]
7. Hepatic and muscular effects of different dietary fat content in VLCAD deficient mice.
Primassin S; Tucci S; Spiekerkoetter U
Mol Genet Metab; 2011 Dec; 104(4):546-51. PubMed ID: 21963783
[TBL] [Abstract][Full Text] [Related]
8. Pre-exercise medium-chain triglyceride application prevents acylcarnitine accumulation in skeletal muscle from very-long-chain acyl-CoA-dehydrogenase-deficient mice.
Primassin S; Tucci S; Herebian D; Seibt A; Hoffmann L; ter Veld F; Spiekerkoetter U
J Inherit Metab Dis; 2010 Jun; 33(3):237-46. PubMed ID: 20446112
[TBL] [Abstract][Full Text] [Related]
9. Corresponding increase in long-chain acyl-CoA and acylcarnitine after exercise in muscle from VLCAD mice.
ter Veld F; Primassin S; Hoffmann L; Mayatepek E; Spiekerkoetter U
J Lipid Res; 2009 Aug; 50(8):1556-62. PubMed ID: 18980943
[TBL] [Abstract][Full Text] [Related]
10. Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse.
Cox KB; Hamm DA; Millington DS; Matern D; Vockley J; Rinaldo P; Pinkert CA; Rhead WJ; Lindsey JR; Wood PA
Hum Mol Genet; 2001 Sep; 10(19):2069-77. PubMed ID: 11590124
[TBL] [Abstract][Full Text] [Related]
11. A heterozygous missense mutation in adolescent-onset very long-chain acyl-CoA dehydrogenase deficiency with exercise-induced rhabdomyolysis.
Hisahara S; Matsushita T; Furuyama H; Tajima G; Shigematsu Y; Imai T; Shimohama S
Tohoku J Exp Med; 2015 Apr; 235(4):305-10. PubMed ID: 25843429
[TBL] [Abstract][Full Text] [Related]
12. Atypical presentation of VLCAD deficiency associated with a novel ACADVL splicing mutation.
Shchelochkov O; Wong LJ; Shaibani A; Shinawi M
Muscle Nerve; 2009 Mar; 39(3):374-82. PubMed ID: 19208414
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic assessment and long-term follow-up of 13 patients with Very Long-Chain Acyl-Coenzyme A dehydrogenase (VLCAD) deficiency.
Laforêt P; Acquaviva-Bourdain C; Rigal O; Brivet M; Penisson-Besnier I; Chabrol B; Chaigne D; Boespflug-Tanguy O; Laroche C; Bedat-Millet AL; Behin A; Delevaux I; Lombès A; Andresen BS; Eymard B; Vianey-Saban C
Neuromuscul Disord; 2009 May; 19(5):324-9. PubMed ID: 19327992
[TBL] [Abstract][Full Text] [Related]
14. Effect of heat stress and bezafibrate on mitochondrial beta-oxidation: comparison between cultured cells from normal and mitochondrial fatty acid oxidation disorder children using in vitro probe acylcarnitine profiling assay.
Li H; Fukuda S; Hasegawa Y; Kobayashi H; Purevsuren J; Mushimoto Y; Yamaguchi S
Brain Dev; 2010 May; 32(5):362-70. PubMed ID: 19589653
[TBL] [Abstract][Full Text] [Related]
15. Fasting-induced oxidative stress in very long chain acyl-CoA dehydrogenase-deficient mice.
Tucci S; Primassin S; Spiekerkoetter U
FEBS J; 2010 Nov; 277(22):4699-708. PubMed ID: 20883455
[TBL] [Abstract][Full Text] [Related]
16. Concerted action of leptin in regulation of fatty acid oxidation in skeletal muscle and liver.
Wein S; Ukropec J; Gasperíková D; Klimes I; Seböková E
Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):244-51. PubMed ID: 17479441
[TBL] [Abstract][Full Text] [Related]
17. Novel mutation of early, perinatal-onset, myopathic-type very-long-chain acyl-CoA dehydrogenase deficiency.
Korematsu S; Kosugi Y; Kumamoto T; Yamaguchi S; Izumi T
Pediatr Neurol; 2009 Aug; 41(2):151-3. PubMed ID: 19589468
[TBL] [Abstract][Full Text] [Related]
18. De novo fatty acid biosynthesis and elongation in very long-chain acyl-CoA dehydrogenase-deficient mice supplemented with odd or even medium-chain fatty acids.
Tucci S; Behringer S; Spiekerkoetter U
FEBS J; 2015 Nov; 282(21):4242-53. PubMed ID: 26284828
[TBL] [Abstract][Full Text] [Related]
19. Very long chain acyl-coenzyme A dehydrogenase deficiency with adult onset.
Smelt AH; Poorthuis BJ; Onkenhout W; Scholte HR; Andresen BS; van Duinen SG; Gregersen N; Wintzen AR
Ann Neurol; 1998 Apr; 43(4):540-4. PubMed ID: 9546340
[TBL] [Abstract][Full Text] [Related]
20. Tissue-specific strategies of the very-long chain acyl-CoA dehydrogenase-deficient (VLCAD-/-) mouse to compensate a defective fatty acid β-oxidation.
Tucci S; Herebian D; Sturm M; Seibt A; Spiekerkoetter U
PLoS One; 2012; 7(9):e45429. PubMed ID: 23024820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
